Methotrexate sodium and Electroencephalogram abnormal - a phase IV clinical study of FDA data

Summary:

Electroencephalogram abnormal is reported as a side effect among people who take Methotrexate sodium (methotrexate sodium), especially for people who are female, 2-9 old, also take Indomethacin, and have Histiocytosis haematophagic.

The phase IV clinical study analyzes which people have Electroencephalogram abnormal when taking Methotrexate sodium. It is created by eHealthMe based on reports of 96,366 people who have side effects when taking Methotrexate sodium from the FDA, and is updated regularly.

What is Methotrexate sodium?

Methotrexate sodium has active ingredients of methotrexate sodium. It is often used in rheumatoid arthritis. eHealthMe is studying from 97,679 Methotrexate sodium users. Check the latest studies of Methotrexate sodium.

What is Electroencephalogram abnormal?

Electroencephalogram abnormal is found to be associated with 605 drugs and 750 conditions by eHealthMe. Check the latest studies of Electroencephalogram abnormal.

On Jul, 20, 2026

96,366 people reported to have side effects when taking Methotrexate sodium.
Among them, 15 people (0.02%) have Electroencephalogram abnormal.

Could Methotrexate sodium cause Electroencephalogram abnormal?

Among these 15 people:

What is the gender of people who have Electroencephalogram abnormal when taking Methotrexate sodium? *

female: 53.33 %
male: 46.67 %

What is the age of people who have Electroencephalogram abnormal when taking Methotrexate sodium? *

What are other drugs people take besides Methotrexate sodium? *

What are other side effects people have besides Electroencephalogram abnormal? *

Confusion: 8 people, 53.33%
Memory Loss: 6 people, 40.00%
Fever: 6 people, 40.00%
Thrombocytopenia (decrease of platelets in blood): 5 people, 33.33%
Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body): 5 people, 33.33%
Ascites (accumulation of fluid in the abdominal cavity): 4 people, 26.67%
Venoocclusive Disease (small veins in the liver are obstructed): 4 people, 26.67%
Drowsiness: 4 people, 26.67%
Speech Impairment (Adult) (inability to speak (adult)): 4 people, 26.67%
Hypotension (abnormally low blood pressure): 4 people, 26.67%

What are the existing conditions these people have? *

Histiocytosis Haematophagic: 3 people, 20.00%
Type 2 Diabetes: 2 people, 13.33%
Juvenile Arthritis (arthritis-related condition that develops in children or teenagers): 2 people, 13.33%
High Blood Pressure: 2 people, 13.33%
Depression: 2 people, 13.33%
Ankylosing Spondylitis (type of arthritis affecting the spine): 2 people, 13.33%
Acute Lymphocytic Leukemia (All) (cancer of the white blood cells characterized by excess lymphoblasts): 2 people, 13.33%
Osteosarcoma (a cancerous (malignant) bone tumour): 1 person, 6.67%
Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 1 person, 6.67%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Methotrexate sodium and have Electroencephalogram abnormal?

- Check whether Electroencephalogram abnormal is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Methotrexate sodium:

Methotrexate sodium (97,679 reports)

Browse all side effects of Methotrexate sodium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Electroencephalogram abnormal:

Electroencephalogram abnormal (605 drugs)

Browse all the conditions that are associated with Electroencephalogram abnormal:

Electroencephalogram abnormal (750 conditions)

Related publications that referenced our studies

Henien M, Carey B, Hullah E, Sproat C, Patel V, "methotrexate-associated osteonecrosis of the jaw: A report of two cases", Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology, 2017 Dec .
Henien M, Carey B, Hullah E, Sproat C, Patel V, "methotrexate-associated osteonecrosis of the jaw: A report of two cases", Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology, 2017 Dec .

How the study uses the data?

The study uses data from the FDA. It is based on methotrexate sodium (the active ingredients of Methotrexate sodium) and Methotrexate sodium (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.